Citius Pharmaceuticals, Inc. (CTXR)

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 4, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Cap	19	22	91	109	177	296
Market Cap Growth	131.94%	-75.31%	-16.54%	-38.55%	-40.30%	412.69%
Enterprise Value	13.36	34.11	94.78	83.1	136.29	227.54
Last Close Price	0.71	1.24	12.52	17.11	30.25	50.75
PE Ratio	-	-0.37	-2.10	-3.07	-5.26	-8.83
PB Ratio	0.20	0.33	1.29	1.20	1.72	2.24
P/TBV Ratio	0.13	0.20	1.20	1.14	1.72	1.67
P/FCF Ratio	-	-0.84	-3.22	-3.74	-6.24	-12.22
P/OCF Ratio	-	-0.84	-3.22	-3.74	-6.24	-12.22
EV/EBITDA Ratio	-	-0.89	-2.27	-2.27	-4.11	-9.74
EV/EBIT Ratio	-	-0.89	-2.26	-2.26	-4.09	-9.67
EV/FCF Ratio	-	-1.28	-3.36	-2.86	-4.81	-9.38
Debt / Equity Ratio	0.02	0.02	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	-0.05	-0.05	-0.01	-0.01	-0.02	-0.04
Debt / FCF Ratio	-0.05	-0.07	-0.01	-0.02	-0.02	-0.04
Net Debt / Equity Ratio	0.02	0.03	0.00	-0.29	-0.40	-0.52
Net Debt / EBITDA Ratio	-0.05	-0.05	-0.01	0.71	1.24	2.96
Net Debt / FCF Ratio	-0.05	-0.07	-0.01	0.90	1.45	2.85
Inventory Turnover	0.04	0	0	-	-	-
Quick Ratio	0.11	0	0	4.58	9.21	17.60
Current Ratio	0.79	0.53	0.31	5.95	9.84	18.28
Return on Equity (ROE)	-47.85%	-52.42%	-47.63%	-33.40%	-28.48%	-27.70%
Return on Assets (ROA)	-29.53%	-31.97%	-38.70%	-34.37%	-26.44%	-25.28%
Return on Invested Capital (ROIC)	-34.27%	-36.10%	-47.08%	-53.60%	-49.66%	-49.70%
Return on Capital Employed (ROCE)	-42.12%	-46.18%	-47.01%	-35.44%	-26.88%	-26.42%
Earnings Yield	-186.41%	-272.58%	-47.68%	-32.55%	-19.01%	-11.33%
FCF Yield	-180.95%	-118.52%	-31.08%	-26.73%	-16.03%	-8.19%
Buyback Yield / Dilution	-107.77%	-64.49%	-11.16%	-3.57%	-34.52%	-177.28%
Total Shareholder Return	-107.77%	-64.49%	-11.16%	-3.57%	-34.52%	-177.28%

Updated Feb 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q